DE69434782D1 - Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide - Google Patents

Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide

Info

Publication number
DE69434782D1
DE69434782D1 DE69434782T DE69434782T DE69434782D1 DE 69434782 D1 DE69434782 D1 DE 69434782D1 DE 69434782 T DE69434782 T DE 69434782T DE 69434782 T DE69434782 T DE 69434782T DE 69434782 D1 DE69434782 D1 DE 69434782D1
Authority
DE
Germany
Prior art keywords
biologically active
active polypeptides
producing recombinant
polypeptides
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69434782T
Other languages
English (en)
Other versions
DE69434782T2 (de
Inventor
Kimishige Ishizaka
Yun-Cai Liu
Toshifumi Mikayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Pharma KK
Original Assignee
Kirin Brewery Co Ltd
La Jolla Institute for Allergy and Immunology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd, La Jolla Institute for Allergy and Immunology filed Critical Kirin Brewery Co Ltd
Application granted granted Critical
Publication of DE69434782D1 publication Critical patent/DE69434782D1/de
Publication of DE69434782T2 publication Critical patent/DE69434782T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE69434782T 1993-05-14 1994-05-13 Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide Expired - Fee Related DE69434782T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6104193A 1993-05-14 1993-05-14
US61041 1993-05-14
PCT/US1994/005354 WO1994026923A1 (en) 1993-05-14 1994-05-13 Method for recombinant production of biologically active polypeptides

Publications (2)

Publication Number Publication Date
DE69434782D1 true DE69434782D1 (de) 2006-08-17
DE69434782T2 DE69434782T2 (de) 2007-06-14

Family

ID=22033267

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69434782T Expired - Fee Related DE69434782T2 (de) 1993-05-14 1994-05-13 Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide

Country Status (13)

Country Link
EP (1) EP0702725B1 (de)
JP (1) JP3578787B2 (de)
KR (1) KR960702868A (de)
CN (1) CN1126494A (de)
AT (1) ATE332392T1 (de)
AU (1) AU692450B2 (de)
CA (1) CA2162865A1 (de)
DE (1) DE69434782T2 (de)
FI (1) FI955463A (de)
HU (1) HU219807B (de)
NO (1) NO954568L (de)
NZ (1) NZ267254A (de)
WO (1) WO1994026923A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910427A (en) * 1995-06-22 1999-06-08 La Jolla Institute For Allergy And Immunology Antigen non-specific glycosylation inhibiting factor derivatives
DE19847690A1 (de) * 1998-10-15 2000-04-20 Brahms Diagnostica Gmbh Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen
EP1234038A1 (de) * 1999-11-19 2002-08-28 Transkaryotic Therapies, Inc. Nucleinsäurekonstrukt zur optimalen herstellung von produkten
DE19957904A1 (de) * 1999-12-01 2001-06-07 Merck Patent Gmbh Insektengift-Allergene mit verminderter IgE-Reaktivität und Verfahren zu ihrer Herstellung
SG176303A1 (en) * 2009-06-10 2012-01-30 Stephen Sanig Res Inst Ltd Methods of generating cells exhibiting phenotypic plasticity
EP2731970B1 (de) 2011-07-15 2018-11-28 MorphoSys AG Antikörper mit kreuzreaktion auf makrophagenmigrations-inhibitorfaktor (mif) und d-dopachrom-tautomerase (d-dt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988007577A1 (en) * 1987-03-31 1988-10-06 Schering Biotech Corporation Glycosylation inhibiting factors
EP0591320A4 (de) * 1991-06-03 1994-11-23 Jolla Inst Allergy Immunolog Hybridom von suppressor-t-zellen.
ATE474597T1 (de) * 1993-05-17 2010-08-15 Cytokine Pharmasciences Inc Inhibition des migrations-inhibitions-faktors in der behandlung von krankheiten bei denen eine cytokin-vermittelte toxizität eine rolle spielt

Also Published As

Publication number Publication date
DE69434782T2 (de) 2007-06-14
NZ267254A (en) 1997-11-24
HU9503249D0 (en) 1996-01-29
CN1126494A (zh) 1996-07-10
AU6948894A (en) 1994-12-12
JPH0884596A (ja) 1996-04-02
HU219807B (hu) 2001-08-28
CA2162865A1 (en) 1994-11-24
FI955463A (fi) 1996-01-12
EP0702725A1 (de) 1996-03-27
FI955463A0 (fi) 1995-11-13
JP3578787B2 (ja) 2004-10-20
AU692450B2 (en) 1998-06-11
KR960702868A (ko) 1996-05-23
NO954568L (no) 1996-01-11
EP0702725A4 (de) 1998-09-30
HUT73213A (en) 1996-06-28
NO954568D0 (no) 1995-11-13
WO1994026923A1 (en) 1994-11-24
ATE332392T1 (de) 2006-07-15
EP0702725B1 (de) 2006-07-05

Similar Documents

Publication Publication Date Title
DE69636831D1 (de) Verfahren zur herstellung heteromultimerer polypeptide
EP0962467A4 (de) Antikörper gegen menschliches parathormon verwandten peptide
AU1986588A (en) Growth hormone receptor
ATE136908T1 (de) Peptide und antikörper, die die integrin- ligandbindung inhibieren
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
ES8606494A1 (es) Un metodo de producir un peptido o polipeptido sintetico.
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
ATE332392T1 (de) Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide
EP0759470A3 (de) Für einen Endoglycoceramidase-Aktivator kodierendes Gen
CA2088068A1 (en) Protein structure of the plant toxin gelonin
ATE313632T1 (de) Durch pflanzen hergestellte rekombinante preduodenale lipase und abgeleitete polypeptide, verfahren zur herstellung und ihre verwendung
HUT64369A (en) Collagen binding protein and method for producing it
CA2187386A1 (en) Gene encoding endo-.beta.-n-acetylglucosaminidase a
HUP0003541A2 (hu) Expressziós vektor polipeptidek javított hatékonyságú előállítására élesztőben
AU3931599A (en) Basb019 proteins and genes from (moraxella catarrhalis), antigens, antibodies, and uses
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
NZ304789A (en) Genes encoding lymphocyte interferon regulatory factory (lsirf) polypeptides that are transcription factors and specific antibodies to them
DE68911713D1 (de) Monoklonale Antikörper, die atriales natriuretisches Polypeptide erkennen, ihre Herstellung und Verwendung.
WO2004089973A3 (en) Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
IL139951A0 (en) Basbo27 proteins and genes from moraxella catarrhalis, intigens, antibodies and uses
UA35624C2 (uk) МОЛЕКУЛА ДНК, ЩО КОДУЄ ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, ВЕКТОР, L-КЛІТИНА, ПРОТЕЇН TGF-<font face="Symbol">b</font>-РОДИНИ, СПОСІБ ЙОГО ОТРИМАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, МОНОКЛОНАЛЬНЕ АНТИТІЛО
DE59509921D1 (de) Integrationsvektoren zur Herstellung von Genen, die rekombinante Antikörper codieren
DE69312502T2 (de) Veränderung von polypeptiden
GB8820284D0 (en) Method for producing recombinant dna proteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: KIRIN PHARMA KABUSHIKI KAISHA, SHIBUYA, TOKYO, JP

8339 Ceased/non-payment of the annual fee